Key Outcomes Recap from Our ADLM 2026 US Exhibition Trip

The ADLM 2026 exhibition (formerly AACC) was successfully held from July 28 to 30 at Anaheim Convention Center, California, USA, and has now come to an end. Hangzhou AllTest Biotech completed its exhibition at Booth 2387 and harvested remarkable results from this top global laboratory medicine and diagnostics event. The three-day show gathered global diagnostic manufacturers, clinical experts and industry elites, offering us an excellent platform to display technologies, communicate with peers and develop overseas partnerships.

We fully exhibited our complete diagnostic product lines based on seven core technical platforms: lateral flow immunoassay, fluorescence immunoassay, PCR, immunoblotting, dry biochemistry, chemiluminescence immunoassay and veterinary diagnostic systems. Our test panels cover cardiac markers, tumor markers, infectious diseases, drugs of abuse and animal testing, alongside supporting devices such as portable LF readers and fluorescence analyzers to deliver integrated POCT and clinical testing solutions.

New launches and hot-selling products were the core highlights on site. We showcased FDA-cleared rapid tests including Strep A assay, UTI test and THC sandwich test, as well as full hormone rapid test kits and professional fluorescence immunoassay systems. Our bestsellers, such as oral fluid multi-drug tests, digital hCG pregnancy tests, drink check tests and multi-drug cups for fentanyl, tramadol and other substances, won widespread praise. Supplementary medical supplies ranging from gastrointestinal healing gel to flexible electronic bronchoscopes were also displayed for visitors' reference.

Our professional team provided live demonstrations, technical consulting and customized cooperation plans for global distributors, hospitals and lab institutions onsite. Multiple preliminary cooperation intentions were signed with overseas clients. This participation boosted our international brand reputation and kept us updated on global POCT trends. Going forward, AllTest will keep optimizing diagnostic products, deepen global collaboration, and jointly drive innovation in worldwide laboratory and point-of-care diagnostics.